Lymphoma, Leukemia and Myeloma Congress is a clinical meeting designed for hematology-oncology professionals navigating rapid change in lymphoma, leukemia, myeloma, and CLL.
New therapies. Earlier-line use. Expanding combinations. Increasing biomarker complexity.
Single-track format — no competing sessions
25+ CME/CE/CMD credits available
Expert-led, data-driven discussions
Focused on real-world implementation